Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aminohydrolases are a class of enzymes that catalyze the hydrolysis of amide bonds, converting amides into their corresponding acids and ammonia or amines. Key examples include Fatty Acid Amide Hydrolase (FAAH), which degrades endogenous fatty acid amides like anandamide and oleamide. They play critical roles in regulating pain sensation, sleep induction, inflammation, and anxiety responses. Inhibition of aminohydrolases is being explored for therapeutic applications.
Inhibition of aminohydrolase activity, leading to increased levels of endogenous substrates.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aminohydrolase.